Results 181 to 190 of about 30,075 (198)

Oral Valganciclovir Is Noninferior to Intravenous Ganciclovir for the Treatment of Cytomegalovirus Disease in Solid Organ Transplant Recipients

American Journal of Transplantation, 2007
Alan Jardine, Anders Åsberg, M Tuncer
exaly  

Ganciclovir

Reactions Weekly, 2015
openaire   +2 more sources

Effect of a Counterion on the Glass Transition Temperature (Tg′) during Lyophilization of Ganciclovir Salt Forms

Molecular Pharmaceutics, 2011
Arvind K Bansal, Lokesh Kumar
exaly  

Ganciclovir

Reactions Weekly, 2017
openaire   +1 more source

Plasma and CSF pharmacokinetics of ganciclovir in nonhuman primates

Cancer Chemotherapy and Pharmacology, 1999
Stacey L Berg, Susan Blaney, S M Blaney
exaly  

Synthesis of Acyclovir, Ganciclovir and Their Prodrugs: A Review

Synthesis, 2000
Hongwu Gao
exaly  

Ganciclovir-loaded albumin nanoparticles: characterization and in vitro release properties

European Journal of Pharmaceutical Sciences, 2001
Juan M. Irache
exaly  

Development and evaluation of nanosized niosomal dispersion for oral delivery of Ganciclovir

Drug Development and Industrial Pharmacy, 2012
Sushama Talegaonkar, Farhan J. Ahmad, Iqbal Ahmad   +2 more
exaly  

Clinical impact of ganciclovir-resistant cytomegalovirus infections in solid organ transplant patients

Transplant Infectious Disease, 2005
Guy Boivin, A Humar
exaly  

Transport of Valganciclovir, a Ganciclovir Prodrug, via Peptide Transporters PEPT1 and PEPT2

Journal of Pharmaceutical Sciences, 2000
Mitsuru Sugawara, Vadivel Ganapathy, You-Jun Fei   +2 more
exaly